MSN Laboratories Private Limited

Overview

MSN Laboratories Private Limited is a leading Indian pharmaceutical company, specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. They have a strong focus on innovation and deliver a wide range of therapeutics in various areas of medicine.

Therapeutic areas

API / Drug Master Files

MSN Laboratories Private Limited holds 273 active (279 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• FRUQUINTINIB [ROUTE CODE FQZ]Active2026-03-31
• OLAPARIB [ROUTE CODE WY]Active2026-03-31
• FRUQUINTINIBActive2026-03-30
• PIRTOBRUTINIB [ROUTE CODE PKZ]Active2026-03-30
• RUXOLITINIB PHOSPHATE [ROUTE CODE: RKP]Active2026-03-29
• SELUMETINIB SULFATEActive2026-03-29
• DAPAGLIFLOZIN PROPANEDIOL (MONOHYDRATE)Active2026-03-29
• BINIMETINIB [ROUTE CODE BTK]Active2026-03-29
• DEXLANSOPRAZOLE (SESQUIHYDRATE)Active2026-03-28
• BINIMETINIB [ROUTE CODE BTQ]Active2026-03-26
• DAPAGLIFLOZIN AMORPHOUSActive2026-03-26
• DEUCRAVACITINIBActive2026-03-24
• PIRTOBRUTINIBActive2026-03-24
• METHOTREXATE USPActive2026-01-21
• ROSUVASTATIN CALCIUM USPActive2026-01-08

Showing 15 of 279 Drug Master Files.

FDA compliance signals